Psychedelic Research

Psychedelic Research is a leading clinical research organization and biotechnology firm dedicated to advancing the field of psychedelic medicine. The company provides comprehensive services including clinical trial design, regulatory strategy, and site management specifically tailored for psychoactive compounds such as psilocybin, MDMA, and LSD. By bridging the gap between academic research and commercial drug development, Psychedelic Research enables sponsors to navigate the unique methodological and legal hurdles associated with Schedule I substances. Their expertise encompasses the integration of psychological support protocols with pharmacological interventions to ensure safety and efficacy in late-stage clinical trials. The firm serves a global clientele of biotech startups and established pharmaceutical companies seeking to address high unmet needs in mental health and neurology.